Tag Archive for: LegoChem Biosciences

Differencesto conventional ADCs reported on LegoChem Biosciences's homepage. © LegoChem Biosciences
partnership

SOTIO licences first cancer ADC from LegoChem Biosciences

SOTIO Biotech a.s. has exercised its first of five exclusive, target-specific options for antibody-drug conjugate (ADC) SOT106 under its agreement with LegoChem Biosciences Inc.

Read more